FDA approves neffy 1 mg for anaphylaxis in children 4 years and older.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 30
- By:
- Publication type:
- Article
Works matching IS 87500507 AND DT 2025 AND VI 41 AND IP 3
Results: 10
1
2
Climate change: Challenges faced by the pediatric population.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 24
- By:
- Publication type:
- Article
3
Inhaled corticosteroid alternatives for young children after Flovent withdrawal.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 21
- By:
- Publication type:
- Article
4
Preventing deficiencies in pediatric food allergies.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 18
- By:
- Publication type:
- Article
5
Uncharacteristic skin findings in a toddler with a history of dermatitis.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
6
Urticarial rash in a male neonate.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
7
Viaskin peanut patch improves treatment benefit through 36 months.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 15
- Publication type:
- Article
8
FDA approves GSK's meningococcal ABCWY vaccine.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 10
- By:
- Publication type:
- Article
9
More screen time is linked to higher stress, depressive symptoms in adolescence.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 9
- By:
- Publication type:
- Article
10
Strengthening allergy awareness in children and teens.
- Published in:
- Contemporary Pediatrics, 2025, v. 41, n. 3, p. 6
- By:
- Publication type:
- Article